TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/24 18:27 | 1/4/24 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dimartino Jorge | CA | O | Chief Me | S | -14 | 1.18 | 0 | -12 | -4 | 315 | D | ||||||||||||||
12/13/23 16:09 | 12/12/23 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dimartino Jorge | CA | O | Chief Me | S | -23 | 1.31 | 0 | -17 | -5 | 327 | D | ||||||||||||||
7/7/23 16:07 | 7/6/23 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dimartino Jorge | CA | O | Chief Me | S | -19 | 1.75 | 0 | -11 | -3 | 345 | D | ||||||||||||||
2/24/23 21:35 | 2/24/23 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dimartino Jorge | CA | O | Chief Me | S | -18 | 1.74 | 0 | -10 | -3 | 355 | D | ||||||||||||||
12/14/22 16:35 | 12/12/22 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dimartino Jorge | CA | O | Chief Me | S | -34 | 1.81 | 0 | -19 | -8 | 219 | D | ||||||||||||||
12/15/21 17:06 | 12/13/21 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dimartino Jorge | CA | O | Chief Me | S | -203 | 12.37 | 0 | -16 | -12 | 118 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |